Nitric oxide synthase isoforms and glomerular hyperfiltration in early diabetic nephropathy

Journal of the American Society of Nephrology

Volumn 11, Issue 1, 2000, Pages 71-79

  Veelken, Roland ^a   Hilgers, Karl F ^b   Hartner, Andrea ^b   Haas, Alexander ^b   Böhmer, Kirsten P ^b   Sterzel, R Bernd ^b  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; DIABETES MELLITUS; DIABETIC NEPHROPATHY; ENDOTHELIUM; ENZYME ACTIVITY; GENE EXPRESSION; GLOMERULUS FILTRATION; IMMUNOHISTOCHEMISTRY; INULIN CLEARANCE; KIDNEY FUNCTION; KIDNEY PLASMA FLOW; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RAT; ULTRAFILTRATION;

EID: 0033982133     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Jacobs C, Selwood NH: Renal replacement therapy for end-stage renal failure in France: Current status and evolutive trends over the last decade. Am J Kidney Dis 25: 188-195, 1995
2. National Institute Of Diabetes DAKD: United States Renal Data System (USRDS), Chapter II: Incidence and prevalence of end-stage renal disease. Available at: http://www.med.umich.edu/ usrds/chapters/ch02/ch02.html, 1998
3. Hostetter TH, Troy JL, Brenner BM: Glomerular hemodynamics in experimental diabetes mellitus. Kidney Int 19: 410-415, 1981
4. Tolins JP, Shultz PJ, Raij L, Brown DM, Mauer SM: Abnormal renal hemodynamic response to reduced renal perfusion pressure in diabetic rats: Role of NO. Am J Physiol 265: F886-F895, 1993
5. Zatz R, de Nucci G: Effects of acute nitric oxide inhibition on rat glomerular microcirculation. Am J Physiol 261: F360-F363, 1991
6. Narita I, Border WA, Ketteler M, Noble NA: Nitric oxide mediates immunologic injury to kidney mesangium in experimental glomerulonephritis. Lab Invest 72: 17-24, 1995
7. Sharma K, Danoff TM, DePiero A, Ziyadeh FN: Enhanced expression of inducible nitric oxide synthase in murine macrophages and glomerular mesangial cells by elevated glucose levels: Possible mediation via protein kinase C. Biochem Biophys Res Commun 207: 80-88, 1995
8. Tilton RG, Chang K, Hasan KS, Smith SR, Petrash JM, Misko TP, Moore WM, Currie MG, Corbett JA: Prevention of diabetic vascular dysfunction by guanidines: Inhibition of nitric oxide synthase versus advanced glycation end-product formation. Diabetes 42: 221-232, 1993
9. Salvemini D, Manning PT, Zweifel BS, Seibert K, Connor J, Currie MG, Needleman P, Masferrer JL: Dual inhibition of nitric oxide and prostaglandin production contributes to the antiinflammatory properties of nitric oxide synthase inhibitors. J Clin Invest 96: 301-308, 1995
10. G-monomethyl-arginine in vitro and in vivo. Eur J Pharmacol 294: 703-712, 1995
11. Veelken R, Hilgers KF, Stetter A, Siebert HG, Schmieder RE, Mann JF: Nerve-mediated antidiuresis and antinatriuresis after air-jet stress is modulated by angiotensin II. Hypertension 28: 825-832, 1996
12. Moore WM, Webber RK, Jerome GM, Tjoeng FS, Misko TP, Currie MG: L-No-(1-iminoethyl)lysine: A selective inhibitor of inducible nitric oxide synthase. J Med Chem 37: 3886-3888, 1994
13. Kreisberg JI, Hoover RL, Karnovsky MJ: Isolation and characterization of rat glomerular epithelial cells in vitro. Kidney Int 14: 21-30, 1978
14. Schulze-Lohoff E, Zanner S, Ogilvie A, Sterzel RB: Extracellular ATP stimulates proliferation of cultured mesangial cells via P2-purinergic receptors. Am J Physiol 263: F374-F383, 1992
15. Chomczynski P: A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. Biotechniques 15: 532-537, 1993
16. Schwartz D, Mendonca M, Schwartz I, Xia Y, Satriano J, Wilson CB, Blantz RC: Inhibition of constitutive nitric oxide synthase (NOS) by nitric oxide generated by inducible NOS after lipopolysaccharide administration provokes renal dysfunction in rats. J Clin Invest 100: 439-448, 1997
17. G-nitro-L-arginine methyl ester treatment in conscious rats. Hypertension 23: 982-986, 1994
18. Losonczy G, Bloch JF, Samsell L, Schoenl M, Venuto R, Baylis C: Impact of surgery on nitric oxide in rats: Evidence for activation of inducible nitric oxide synthase. Kidney Int 51: 1943-1949, 1997
19. Hogaboam CM, Collins SM, Blennerhassett MG: Effects of oral L-NAME during Trichinella spiralis infection in rats. Am J Physiol 271: G338-G346, 1996
20. Beck KF, Mohaupt MG, Sterzel RB: Endothelin-1 inhibits cytokine-stimulated transcription of inducible nitric oxide synthase in glomerular mesangial cells. Kidney Int 48: 1893-1899, 1995
21. Karlsen AE, Andersen HU, Vissing H, Larsen PM, Fey SJ, Cuartero BG, Madsen OD, Petersen JS, Mortensen SB: Cloning and expression of cytokine-inducible nitric oxide synthase cDNA from rat islets of Langerhans. Diabetes 44: 753-758, 1995
22. Xu W, Charles IG, Liu L, Moncada S, Emson P: Molecular cloning and structural organization of the human inducible nitric oxide synthase gene (NOS2). Biochem Biophys Res Commun 219; 784-788, 1996
23. Mai M, Hilgers KF, Geiger H: Experimental studies on the role of intercellular adhesion molecule-1 and lymphocyte function-associated antigen-1 in hypertensive nephrosclerosis. Hypertension 28: 973-979, 1996
24. Eissa NT, Strauss AJ, Haggerty CM, Choo EK, Chu SC, Moss J: Alternative splicing of human inducible nitric-oxide synthase mRNA: Tissue-specific regulation and induction by cytokines. J Biol Chem 271: 27184-27187, 1996
25. Forstermann U, Boissel JP, Kleinert H: Expressional control of the "constitutive" isoforms of nitric oxide synthase (NOS I and NOS III). PASEB J 12: 773-790, 1998
26. Corson MA, James NL, Latta SE, Nerem RM, Berk BC, Harrison DG: Phosphorylation of endothelial nitric oxide synthase in response to fluid shear stress. Circ Res 79: 984-991, 1996
27. Komers R, Allen TJ, Cooper ME: Role of endothelium-derived nitric oxide in the pathogenesis of the renal hemodynamic changes of experimental diabetes. Diabetes 43: 1190-1197, 1994
28. Mattar AL, Fujihara CK, Ribeiro MO, de Nucci G, Zatz R: Renal effects of acute and chronic nitric oxide inhibition in experimental diabetes. Nephron 74: 136-143, 1996
29. Soulis T, Thallas V, Youssef S, Gilbert RE, McWilliam BG, Murray-McIntosh RP, Cooper ME: Advanced glycation end products and their receptors co-localise in rat organs susceptible to diabetic microvascular injury. Diabetologia 40: 619-628, 1997
30. Choi KC, Lee SC, Kim SW, Kim NH, Lee JU, Kang YJ: Role of nitric oxide in the pathogenesis of diabetic nephropathy in streptozotocin-induced diabetic rats. Korean J Intern Med 14: 32-41, 1999
31. Michel T, Li GK, Busconi L: Phosphorylation and subcellular translocation of endothelial nitric oxide synthase. Proc Natl Acad Sci USA 90: 6252-6256, 1993
32. Tilton RG, Kawamura T, Chang KC, Ido Y, Bjercke RJ, Stephan CC, Brock TA, Williamson JR: Vascular dysfunction induced by elevated glucose levels in rats is mediated by vascular endothelial growth factor. J Clin Invest 99: 2192-2202, 1997
33. Kroll J, Waltenberger J: VEGF-A induces expression of eNOS and iNOS in endothelial cells via VEGF receptor-2 (KDR). Biochem Biophys Res Commun 252: 743-746, 1998
34. Sugimoto H, Shikata K, Matsuda M, Kushiro M, Hayashi Y, Hiragushi K, Wada J, Makino H: Increased expression of endothelial cell nitric oxide synthase (ecNOS) in afferent and glomerular endothelial cells is involved in glomerular hyperfiltration of diabetic nephropathy. Diabetologia 41: 1426-1434, 1998
35. Pieper GM: Enhanced, unaltered and impaired nitric oxide-mediated endothelium-dependent relaxation in experimental diabetes mellitus: Importance of disease duration. Diabetologia 42: 204-213, 1999
36. Craven PA, Studer RK, DeRubertis FR: Impaired nitric oxide-dependent cyclic guanosine monophosphate generation in glomeruli from diabetic rats: Evidence for protein kinase C-mediated suppression of the cholinergic response. J Clin Invest 93: 311-320, 1994